Eurofins-Cerep SA (ENXTPA: ALECR)
Health Care · Life Sciences Tools & Services · FR
€18,100.00
+19.87% today · -0.5% 1Y
Eurofins-Cerep SA (ENXTPA: ALECR) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $102.18M and employs 209 people.
Over the last twelve months the share price has lost 0.5%, trading between 15.00K and 18.60K.
Tweenvest scores Eurofins-Cerep SA across four factors: quality 74/100, value 51/100, growth 25/100. Its strongest factor is quality.
ALECR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $102.18M
- Revenue (TTM)
- $48.26M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.11
- 52-week high
- €18,600.00
- 52-week low
- €15,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.04K
- Employees
- 209
- Next earnings
- —
About Eurofins-Cerep SA
Established in 1989 and headquartered in Vienne, France, Eurofins Cerep SA delivers a broad spectrum of drug discovery support to pharmaceutical and biotechnology enterprises across the globe. The company's specialized offerings include the management of chemical compounds, high-throughput screening capabilities, in vitro safety assessments, optimization of lead compounds (SAR profiling), in vitro ADME evaluations, and in vivo pharmacokinetic (PK) studies. Furthermore, it provides expert services in assay development and design. The organization, originally known as Cerep SA, officially adopted the name Eurofins Cerep SA in June 2014.
- ISIN
- FR0013256518
- Founded
- 1989
- Listed since
- Apr 12, 2000
- Exchange
- Euronext Paris
- Currency
- EUR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Curiosis, Inc.KOSDAQ: A494120 | $110.47M | ₩9,750.00 | +19.34% |
| MaxCyte, Inc.NasdaqGS: MXCT | $110.43M | $1.04 | -2.80% |
| Borosil Scientific LimitedBSE: 544184 | $103.70M | Rs112.25 | -2.86% |
| Selvita S.A.WSE: SLV | $103.37M | zł22.70 | +3.65% |
| Macrogen, Inc.KOSDAQ: A038290 | $101.35M | ₩12,590.00 | +4.14% |
| Ryvu Therapeutics S.A.WSE: RVU | $92.15M | zł16.06 | +3.61% |
| Celemics, Inc.KOSDAQ: A331920 | $88.59M | ₩10,670.00 | -5.99% |
| Nanoform Finland OyjHLSE: NANOFH | $81.07M | €0.77 | -8.33% |
Figures last refreshed Oct 4, 2026.